The numerous active agents and possible drug combinations for the treatment of multiple myeloma present challenges in terms of the best regimens for first-line therapy, role of transplantation, and maintenance therapy. Should treatment approaches achieve cure or disease control? This Review provides an update on the treatment of multiple myeloma, with a focus on recent advances and newly diagnosed disease.